As age increases, the chance of a patient with hematological malignancies having further complications increases. Speaking from the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA., Raúl Córdoba, MD, PhD, MS, of the Fundación Jiménez Diaz University Hospital, Madrid, Spain, introduces the Geriatric Assessment in Hematology (GAH) scale: a tool used to identify elderly patients with multiple myeloma, chronic lymphocytic leukemia or high-risk myelodysplastic syndromes that are fit and can be treated similarly to young patients.